DNA particles that mimic viruses hold promise as vaccines
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
MIT’s tiny technologies go to Washington
Cancer nanomedicine was on display at the 2023 White House Demo Day.
3 Questions: Darrell Irvine on making HIV vaccines more powerful
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
MIT engineers design more powerful RNA vaccines
The new approach could lead to intranasal vaccines for Covid-19 and other respiratory diseases.
A snapshot of cancer vaccine development
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
MIT researchers to lead a new center for continuous mRNA manufacturing
A pilot-scale system, enabled by an $82 million award from the FDA, aims to accelerate the development and production of mRNA technologies.
Vaccine delivers a boost to T cell therapy
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
Putting the STING into cancer immunotherapy
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
Four researchers with MIT ties earn 2023 Schmidt Science Fellowships
The illustrious prize supports early-career scientists and engineers as they pursue interdisciplinary work.
Chemists’ technique reveals whether antibodies neutralize SARS-CoV-2
The method could enable a rapid test to determine whether individuals are producing antibodies that help protect against Covid-19.
Vaccine printer could help vaccines reach more people
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
Championing health workers to lead vaccination efforts in Uganda
A survey to measure who was getting vaccinated against Covid-19 in Uganda finds health workers had an important role to play.
Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies
The global health care company Sanofi is providing $25 million to advance RNA research.
Creating a versatile vaccine to take on Covid-19 in its many guises
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
New purification method could make protein drugs cheaper
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.